Garsky VM - Search Results

1

Identification of HPV-16 E7 peptides that are potent antagonists of E7 binding to the retinoblastoma suppressor protein.

Jones RE, Wegrzyn RJ, Patrick DR, Balishin NL, Vuocolo GA, Riemen MW, Defeo-Jones D, Garsky VM, Heimbrook DC, Oliff A. Jones RE, et al. Among authors: garsky vm. J Biol Chem. 1990 Aug 5;265(22):12782-5. J Biol Chem. 1990. PMID: 2198278 Free article.

2

Specific N-methylations of HPV-16 E7 peptides alter binding to the retinoblastoma suppressor protein.

Jones RE, Heimbrook DC, Huber HE, Wegrzyn RJ, Rotberg NS, Stauffer KJ, Lumma PK, Garsky VM, Oliff A. Jones RE, et al. Among authors: garsky vm. J Biol Chem. 1992 Jan 15;267(2):908-12. J Biol Chem. 1992. PMID: 1309779 Free article.

3

Human papillomavirus type 16 E7 protein inhibits DNA binding by the retinoblastoma gene product.

Stirdivant SM, Huber HE, Patrick DR, Defeo-Jones D, McAvoy EM, Garsky VM, Oliff A, Heimbrook DC. Stirdivant SM, et al. Among authors: garsky vm. Mol Cell Biol. 1992 May;12(5):1905-14. doi: 10.1128/mcb.12.5.1905-1914.1992. Mol Cell Biol. 1992. PMID: 1314947 Free PMC article.

4

Minimal ligand analysis of gastrin releasing peptide. Receptor binding and mitogenesis.

Heimbrook DC, Boyer ME, Garsky VM, Balishin NL, Kiefer DM, Oliff A, Riemen MW. Heimbrook DC, et al. Among authors: garsky vm. J Biol Chem. 1988 May 25;263(15):7016-9. J Biol Chem. 1988. PMID: 2835360 Free article.

5

Structure-function analysis of synthetic and recombinant derivatives of transforming growth factor alpha.

Defeo-Jones D, Tai JY, Wegrzyn RJ, Vuocolo GA, Baker AE, Payne LS, Garsky VM, Oliff A, Riemen MW. Defeo-Jones D, et al. Among authors: garsky vm. Mol Cell Biol. 1988 Aug;8(8):2999-3007. doi: 10.1128/mcb.8.8.2999-3007.1988. Mol Cell Biol. 1988. PMID: 2850475 Free PMC article.

6

Protein domains governing interactions between E2F, the retinoblastoma gene product, and human papillomavirus type 16 E7 protein.

Huang PS, Patrick DR, Edwards G, Goodhart PJ, Huber HE, Miles L, Garsky VM, Oliff A, Heimbrook DC. Huang PS, et al. Among authors: garsky vm. Mol Cell Biol. 1993 Feb;13(2):953-60. doi: 10.1128/mcb.13.2.953-960.1993. Mol Cell Biol. 1993. PMID: 7678696 Free PMC article.

7

Antibodies against amino acids 1-15 of tumor necrosis factor block its binding to cell-surface receptor.

Socher SH, Riemen MW, Martinez D, Friedman A, Tai J, Quintero JC, Garsky V, Oliff A. Socher SH, et al. Proc Natl Acad Sci U S A. 1987 Dec;84(24):8829-33. doi: 10.1073/pnas.84.24.8829. Proc Natl Acad Sci U S A. 1987. PMID: 2827156 Free PMC article.

8

The synthesis of a prodrug of doxorubicin designed to provide reduced systemic toxicity and greater target efficacy.

Garsky VM, Lumma PK, Feng DM, Wai J, Ramjit HG, Sardana MK, Oliff A, Jones RE, DeFeo-Jones D, Freidinger RM. Garsky VM, et al. J Med Chem. 2001 Nov 22;44(24):4216-24. doi: 10.1021/jm0101996. J Med Chem. 2001. PMID: 11708923

9

PSA-specific and non-PSA-specific conversion of a PSA-targeted peptide conjugate of doxorubicin to its active metabolites.

Wong BK, DeFeo-Jones D, Jones RE, Garsky VM, Feng DM, Oliff A, Chiba M, Ellis JD, Lin JH. Wong BK, et al. Among authors: garsky vm. Drug Metab Dispos. 2001 Mar;29(3):313-8. Drug Metab Dispos. 2001. PMID: 11181501

10

Design and synthesis of a pro-drug of vinblastine targeted at treatment of prostate cancer with enhanced efficacy and reduced systemic toxicity.

Brady SF, Pawluczyk JM, Lumma PK, Feng DM, Wai JM, Jones R, DeFeo-Jones D, Wong BK, Miller-Stein C, Lin JH, Oliff A, Freidinger RM, Garsky VM. Brady SF, et al. Among authors: garsky vm. J Med Chem. 2002 Oct 10;45(21):4706-15. doi: 10.1021/jm020139f. J Med Chem. 2002. PMID: 12361397

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

81 results

Search Page

Filters